Literature DB >> 6338038

Persistent glucose production during glucose infusion in the neonate.

R M Cowett, W Oh, R Schwartz.   

Abstract

In adults, glucose infusion results in a decreased glucose production rate (GPR) as a mechanism for maintaining euglycemia. To document the development of glucose homeostasis, we derived the GPR in 23 preterm appropriate for gestational age infants, 14 term appropriate for gestational age infants, and in 6 adults. After a 3-h fast, the average plasma glucose and insulin concentration was measured and the GPR was derived. During glucose infusion (5.6 +/- 0.3 mg X kg-1 min-1), compared with saline controls, the preterms had a rise in plasma glucose and plasma insulin, and the GPR was 1.4 mg X kg-1 min-1 (range, 0-4.4) vs. 3.0 mg X kg-1 min-1 (range, 1.8-4.1) (saline controls). In the term infants, only the plasma insulin concentration was elevated when the glucose infused (5.7 +/- 0.3 mg X kg-1 min-1) infants were compared with the saline controls and GPR was 0.4 X kg-1 min-1 (range, 0-2.6) vs. 3.4 mg X kg-1 min-1 (range, 2.8-5.7) (saline controls). In comparison to saline infused adults, glucose infusion (3.2 +/- 0.1 mg X kg-1 min-1) resulted in a significant rise in plasma glucose and in plasma insulin; and the GPR was reduced to 0.1 mg X kg-1 min-1 (range, 0-0.3) from 2.0 mg X kg-1 min-1 (range, 1.5-2.4). 5 of 13 preterms and 2 of 7 term infants had persistent GPR during glucose infusion; in contrast, the GPR in all adults was unmeasurable. There was no correlation between the plasma glucose concentration and the GPR in the newborn or in the adult. Both newborns and adults did have a correlation between plasma insulin concentration and the GPR; however, there was considerable variability in the neonate. We conclude that there are significant developmental differences in neonatal glucose homeostasis and that insulin is important in neonatal hormonal control of glucose production.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338038      PMCID: PMC436894          DOI: 10.1172/jci110791

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Homeostatic responses to glucose loading in newborn and young dogs.

Authors:  S Varma; H Nickerson; J S Cowan; G Hetenyi
Journal:  Metabolism       Date:  1973-11       Impact factor: 8.694

Review 2.  Role of insulin in the hepatic handling of glucose.

Authors:  L L Madison
Journal:  Arch Intern Med       Date:  1969-03

3.  Relations between blood glucose and hepatic glucose production in newborn dogs.

Authors:  G Hetenyi; S Varma; J S Cowan
Journal:  Br Med J       Date:  1972-06-10

4.  A colorimetric serum glucose determination using hexokinase and glucose-6-phosphate dehydrogenase.

Authors:  J J Carroll; N Smith; A L Babson
Journal:  Biochem Med       Date:  1970-09

5.  Model for the investigation of intractable hypoglycemia: insulin-glucose interrelationships during steady state infusions.

Authors:  P A Adam; K King; R Schwartz
Journal:  Pediatrics       Date:  1968-01       Impact factor: 7.124

6.  Endogenous glucose production during constant glucose infusion in the newborn lamb.

Authors:  R M Cowett; J B Susa; W Oh; R Schwartz
Journal:  Pediatr Res       Date:  1978-08       Impact factor: 3.756

7.  Glucose intolerance in infants of very low birth weight. I. Incidence of hyperglycemia in infants of birth weights 1,100 grams or less.

Authors:  H S Dweck; G Cassady
Journal:  Pediatrics       Date:  1974-02       Impact factor: 7.124

8.  Measurement of "true" glucose production rates in infancy and childhood with 6,6-dideuteroglucose.

Authors:  D M Bier; R D Leake; M W Haymond; K J Arnold; L D Gruenke; M A Sperling; D M Kipnis
Journal:  Diabetes       Date:  1977-11       Impact factor: 9.461

9.  Glucose metabolism in man: responses to intravenous glucose infusion.

Authors:  R R Wolfe; J R Allsop; J F Burke
Journal:  Metabolism       Date:  1979-03       Impact factor: 8.694

10.  In-vivo measurement of glucose and alanine metabolism with stable isotopic tracers.

Authors:  D M Bier; K J Arnold; W R Sherman; W H Holland; W F Holmes; D M Kipnis
Journal:  Diabetes       Date:  1977-11       Impact factor: 9.461

View more
  23 in total

Review 1.  Hypoglycaemia of the newborn: a review.

Authors:  A F Williams
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

2.  Sustained hypoxemia in late gestation potentiates hepatic gluconeogenic gene expression but does not activate glucose production in the ovine fetus.

Authors:  Amanda K Jones; Paul J Rozance; Laura D Brown; David A Goldstrohm; William W Hay; Sean W Limesand; Stephanie R Wesolowski
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-04-09       Impact factor: 4.310

3.  Enzymes of lysosomal origin in the serum of infants of diabetic mothers behavior in the first days after birth.

Authors:  G Goi; A B Burlina; C Moreschi; G Motta; C Bairati; A Lombardo; A Marini; G Tettamanti
Journal:  Acta Diabetol Lat       Date:  1988 Oct-Dec

4.  Blood glucose controller for neonatal intensive care: virtual trials development and first clinical trials.

Authors:  Aaron Le Compte; J Geoffrey Chase; Adrienne Lynn; Chris Hann; Geoffrey Shaw; Xing-Wei Wong; Jessica Lin
Journal:  J Diabetes Sci Technol       Date:  2009-09-01

5.  Low birthweight infants and total parenteral nutrition immediately after birth. II. Randomised study of biochemical tolerance of intravenous glucose, amino acids, and lipid.

Authors:  N Murdock; A Crighton; L M Nelson; J S Forsyth
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-07       Impact factor: 5.747

6.  Role of placental insufficiency and intrauterine growth restriction on the activation of fetal hepatic glucose production.

Authors:  Stephanie R Wesolowski; William W Hay
Journal:  Mol Cell Endocrinol       Date:  2015-12-23       Impact factor: 4.102

7.  Effect of diazoxide or glucagon on hepatic glucose production rate during extreme neonatal hypoglycaemia.

Authors:  A Mehta; R Wootton; K N Cheng; P Penfold; D Halliday; T E Stacey
Journal:  Arch Dis Child       Date:  1987-09       Impact factor: 3.791

8.  Intravenous glucose suppresses glucose production but not proteolysis in extremely premature newborns.

Authors:  D E Hertz; C A Karn; Y M Liu; E A Liechty; S C Denne
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

9.  A C-Peptide-Based Model of Pancreatic Insulin Secretion in Extremely Preterm Neonates in Intensive Care.

Authors:  Jennifer L Dickson; Jane Alsweiler; Cameron A Gunn; Christopher G Pretty; J Geoffrey Chase
Journal:  J Diabetes Sci Technol       Date:  2015-08-07

10.  The role of pancreatic insulin secretion in neonatal glucoregulation. II. Infants with disordered blood glucose homoeostasis.

Authors:  J M Hawdon; A Aynsley-Green; K Bartlett; M P Ward Platt
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.